Gerresheimer sells Centor and PPP unit to Apax Funds for €1.5B; Resilience and Lilly invest $750M in Ohio manufacturing; Teva books $70M European impairment charge.
July 30, 2026 09:30 AM EDT
Manufacturing
Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacity
Anna Brown
News Reporter
Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to…
The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience’s contract manufacturing…
Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare…
Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
Atea's BEM/RZR matches Gilead's Epclusa in Phase 3; AbCellera partners with Vertex for $28M; LB Pharma raises $150M for…
Four months after Theravance Biopharma shut down its R&D unit, laid | Four months after Theravance Biopharma shut down its R&D…
